United States · Research startup

IconOVir Bio

IconOVir Bio is a biotechnology company based in San Diego, California, founded in 2018.

Funding reportedLast round: Series A

ResearchSan Diego, United States

About IconOVir Bio

IconOVir Bio is a biotechnology company based in San Diego, California, founded in 2018.

The company specializes in developing oncolytic virus therapies aimed at treating cancer, particularly solid tumors and advanced cancers. Its core platform is a proprietary oncolytic virus system, developed from research by Dr. Clodagh O’Shea at the Salk Institute, designed to enhance personalized cancer therapy. The lead candidate from IconOVir Bio is ICVB-1042, which is administered intravenously and is currently in a Phase 1 clinical trial for advanced solid tumors, having started in July 2023. The company is focused on research and development, working on differentiated oncolytic virus candidates that exhibit tumor selectivity and broad tumor-cell infectivity, targeting patients with cancer and the oncology treatment community.

What company datasets say IconOVir Bio raised

Funding, as reported

Reported in all$77Min dollars
Rounds1
Last roundSeries A
Last round size$77M
Last round dateJan 2021
SEC Form D$117M sold, 3 filings, last Jun 2024

Founders and team

From the SEC filings it signed: 9 on the team.

  • David A. ChangDirector, Promoteri
  • David M. TanenExecutive Officer, Promoteri
  • Heba M. NowyhedExecutive Officeri
  • John A. HuynhExecutive Officeri
  • Joshua A. KazamDirector, Promoteri
  • Julie A. MaltzmanExecutive Officeri
  • Mark A. McCamishExecutive Officer, Directori
  • Nicole M. van de LeuvExecutive Officeri
  • Sean A. AlgeoExecutive Officer, Promoteri

On the board, as filediHelen S. KimJakob S. LovenWilliam S. Kaelin

On a portfolio page

Investors who name them

Each firm lists IconOVir Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

health carebiotechnology researchmedical researchbiotech researchclinical researchhospital & health carecancer immunotherapymedicalcancer treatmenthealthbiotechnologyoncology biotechdrug developmentresearch and development in the physicalengineeringbiotech

Built with from their website

WordPress.orgFont AwesomeElementorViewport MetaHello ElementorKnowBe4SucuriMicrosoft ExchangeMySQLMicrosoft 365 Apps & Services

+8 more

Mobile FriendlyOpen GraphjQueryRSSYoast SEOZoom MeetingsYoastZendesk for Service

Sector
Research
Industry code
NAICS 541714, SIC 2834, 2836, 8731
Region
California
Revenue
$3.1M a year, as listed

Research in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put IconOVir Bio in front of investors. Or tell us what we have wrong.